Aspira Pathlab Diagnostics Ltd vs Family Care Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 29, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of March 2024 .The P/E Ratio of Family Care Hospitals Ltd is 0 as of March 2024 . The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 31.91 crore as of March 2024 .The Market Cap of Family Care Hospitals Ltd is ₹ 0 crore as of March 2024 . The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of Family Care Hospitals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of Family Care Hospitals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of Family Care Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Family Care Hospitals Ltd changed from 6.17 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Family Care Hospitals Ltd

Family Care Hospitals Limited was initially established as a Partnership firm in 1982.
It became a Public Limited Company in September 1994 under the name of Pharma Offset Limited.
Thereafter, the name of the Company was changed from Pharma Offset Limited to Pharma Com (India) Limited in June, 2000.
Again, it was changed from Pharma Com (India) Limited to Count N Denier (India) Limited in March, 2012.
Further, it got changed from Count N Denier (India) Limited to Scandent Imaging Limited in June, 2015 and from Scandent Imaging Limited to Family Care Hospitals Limited in June, 2022.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Family Care Hospitals Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Family Care Hospitals Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 131 Cr while Market cap of Family Care Hospitals Ltd is 9 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Family Care Hospitals Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Family Care Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Family Care Hospitals Ltd?

As of October 29, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹127.45. On the other hand, Family Care Hospitals Ltd stock price is INR ₹1.83.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Family Care Hospitals Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Family Care Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.